Sulfated polysaccharide purified from Ecklonia cava accelerates antithrombin III-mediated plasma proteinase inhibition

Surface plasmon resonance is an important technique for studying molecular interactions and was used to investigate the molecular interaction of anticoagulant sulfated polysaccharides purified from an enzymatic hydrolysate of the brown alga Ecklonia cava (ECA) with blood coagulation factors. In a direct binding assay, binding affinity between ECA/antithrombin III (ATIII) and activated blood coagulation factors was in the order: factor VIIa (FVIIa) > factor Xa (FXa) > thrombin (FIIa); kinetic analysis determined KD values of ECA for FVIIa, FXa, and FIIa of 15.1, 45.0 and 65.0 nM, respectively. Therefore, ECA strongly and selectively (FVII, FX, and FII) enhanced ATIII-mediated coagulation factor inhibition in both the extrinsic and common coagulation pathways. This may contribute to its high anticoagulant activity in vitro. The low cytotoxicity of ECA to venous endothelial cell line (ECV-304) also expands its value in future in vivo studies. However, to utilize it as a model for novel anticoagulant agents, its possible interference with other anticoagulant mechanisms must be addressed.

[1]  Kil-Nam Kim,et al.  Antiproliferative and antioxidant properties of an enzymatic hydrolysate from brown alga, Ecklonia cava. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[2]  R. Rosenberg,et al.  Natural anticoagulant mechanisms. , 1984, The Journal of clinical investigation.

[3]  S. Olson,et al.  Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin. , 1993, Methods in enzymology.

[4]  Won‐Kyo Jung,et al.  An anticoagulative polysaccharide from an enzymatic hydrolysate of Ecklonia cava , 2005 .

[5]  U. Desai.  New antithrombin‐based anticoagulants , 2004, Medicinal research reviews.

[6]  K. Higashi-Okai,et al.  Identification of heterogenous antimutagenic activities in the extract of edible brown seaweeds, Laminaria japonica (Makonbu) and Undaria pinnatifida (Wakame) by the umu gene expression system in Salmonella typhimurium (TA1535/pSK1002). , 1993, Mutation research.

[7]  M. Griffith.  Chapter 9A Inhibitors: antithrombin III and heparin , 1986 .

[8]  M. Shanmugam,et al.  Heparinoid-active sulphated polysaccharides from marine algae as potential blood anticoagulant agents. , 2000 .

[9]  K. Higashi-Okai,et al.  Identification of antimutagenic activities in the extract of an edible brown alga, Hijikia fusiforme (Hijiki) by umu gene expression system in Salmonella typhimurium (TA 1535/pSK 1002) , 1994 .

[10]  T S Edgington,et al.  Macromolecular Substrate Affinity for the Tissue Factor-Factor VIIa Complex Is Independent of Scissile Bond Docking* , 1999, The Journal of Biological Chemistry.

[11]  K Fujikawa,et al.  The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.

[12]  T. Nishino,et al.  Antithrombin activity of a fucan sulfate from the brown seaweed Ecklonia kurome. , 1991, Thrombosis research.

[13]  J. Minna,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. , 1987, Cancer research.

[14]  K. Mann,et al.  Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. , 1993, The Journal of biological chemistry.

[15]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[16]  K. Matsubara,et al.  Antiangiogenic properties of a sulfated galactan isolated from a marine green alga, Codium cylindricum , 2004, Journal of Applied Phycology.

[17]  G M Oosta,et al.  The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. , 1980, The Journal of biological chemistry.